News & Analysis as of

Research and Development › Merck

Hogan Lovells

Coronavirus: The Hill and the Headlines, January 2021 # 14

Hogan Lovells on

In Washington: Moderna is accelerating its testing on booster shots to vaccinate against the different variants and mutations in strains of COVID. Alarm bells have sounded after research shows the Moderna vaccine was six...more

Goodwin

New Results Presented at ESMO: Merck’s Keytruda® Has Potential to be Used as First-Line Therapy for Non-Small Cell Lung Cancer

Goodwin on

At yesterday’s European Society for Medical Oncology (ESMO) meeting, Merck Sharp & Dohme Corp. announced positive data from two studies regarding its Keytruda ® (pembrolizumab) biologic. According to Merck’s press release,...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide